絞り込み

16645

広告

新型ウイルス対応医師ら職場で“バイ菌”扱い 学会が抗議声明

新型コロナウイルスの集団感染が起きたクルーズ船などで、対応を行った医師や看護師らが職場などで不当な扱いを受けているとして、災害対応を行う医療関係者でつくる学会が...

  1. 新型肺炎 インフルエンザ治療薬など使用 ...
  2. 新型肺炎 クルーズ下船後に陽性 栃木の6...
  3. 【動画】「dry cough」の意味を予...
  4. G20開幕 肺炎議題に 世界経済リスク、...

ニュース一覧

The application of CRISPR-Cas9 gene editing technology in viral infection diseases.

著者 Lijuan Y , Siqi H , Fei G
Yi Chuan.2015 May 20 ; 37(5):412-418.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (29view , 0users)

Medical

The RNA-guided Cas9 nuclease from microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system has been used to facilitate efficient genome engineering in eukaryotic cells. The specific targeted genome is recognized and cut by gRNA-directed CRISPR/Cas9 complex, specifically by the endonuclease Cas9. The targeted gene locus could be repaired either by homology-directed repair or nonhomologous end joining, thus achieving a desired editing outcome. Viruses infect cells through specific receptors, and then the viral genome is transcribed, replicated and translated to complete its life cycle. As a result, some DNA virus and retrovirus genomes are integrated into the cellular genome. Gene therapy is a new trend to treat viral infected diseases. Given its designable sequence-specific editing of the targeted genome, CRISPR/Cas9 has tremendous potential in treating persistent and latent viral infections. In this review, we summarize the mechanism and progresses of CRISPR/Cas9, and also highlight its therapeutic application in infectious diseases.
PMID: 25998428 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード